Table 2. Characteristics of CRC patients between PRKACB high and low groups
High group (n=229) vs Low group (n=228)
High Low P
Gender* FEMALE (n=216) 100 116 0.197
GENDER (n=1) 1 0
MALE (n=240) 128 112
Age, median(IQR), years* 68.0(19.0) 69.0(20.0) 0.490
>60 (n=319) 159 160 1.000
≤60 (n=137) 69 68
BMI, kg/m2 <18.5 (n=1) 0 1 0.239
>29.99 (n=74) 44 30
18.5-24.99 (n=77) 34 43
25-29.99 (n=80) 43 37
NA (n=225) 108 117
Tumor Stage PATHOLOGIC_T (n=1) 1 0 0.098
T1 (n=11) 4 7
T2 (n=77) 41 36
T3 (n=311) 163 148
T4 (n=28) 10 18
T4A (n=19) 8 11
T4B (n=9) 1 8
TIS (n=1) 1 0
Lymph Node Stage N0 (n=268) 139 129 0.537
N1 (n=73) 33 40
N1A (n=15) 9 6
N1B (n=15) 5 10
N1C (n=2) 2 0
N2 (n=62) 31 31
N2A (n=8) 4 4
N2B (n=13) 5 8
PATHOLOGIC_N (n=1) 1 0
Metastasis Stage M0 (n=334) 171 163 0.428
M1 (n=53) 20 33
M1A (n=9) 5 4
M1B (n=3) 2 1
MX (n=50) 26 24
PATHOLOGIC_M (n=1) 1 0
AJCC stage NA (n=4) 3 1 0.270
PATHOLOGIC_STAGE (n=1) 1 0
STAGE I (n=74) 35 39
STAGE IA (n=1) 1 0
STAGE II (n=30) 21 9
STAGE IIA (n=136) 69 67
STAGE IIB (n=10) 3 7
STAGE IIC (n=1) 1 0
STAGE III (n=20) 13 7
STAGE IIIA (n=8) 5 3
STAGE IIIB (n=59) 29 30
STAGE IIIC (n=41) 18 23
STAGE IV (n=46) 17 29
STAGE IVA (n=17) 9 8
STAGE IVB (n=2) 1 1
Lymphovascular invasion LYMPHATIC_INVASION (n=1) 1 0 0.428
NA (n=2) 1 1
NO (n=248) 130 118
YES (n=164) 75 89
Perineural Invasion NA (n=7) 2 5 0.429
NO (n=133) 72 61
PERINEURAL_INVASION_PRESENT (n=1) 1 0
YES (n=46) 23 23
Vascular invasion NA (n=2) 0 2 0.356
NO (n=299) 147 152
VENOUS_INVASION (n=1) 1 0
YES (n=96) 50 46
Race Category AMERICAN INDIAN OR ALASKA NATIVE (n=1) 1 0 0.765
ASIAN (n=11) 6 5
BLACK OR AFRICAN AMERICAN (n=59) 31 28
RACE (n=1) 1 0
WHITE (n=213) 111 102
Person Neoplasm Status NA (n=15) 6 9 0.253
PERSON_NEOPLASM_CANCER_STATUS (n=1) 1 0
TUMOR FREE (n=198) 106 92
WITH TUMOR (n=206) 94 112